NASDAQ: AHCO at https://www.webull.com/quote/nasdaq-ahco is a leading supplier in the United States of home health supplies, home health care and support services. The products and services on offer include sleep treatment facilities, supplies of and related services for persons with obstacle sleep, home care facilities for patients and other facilities discharged from acute care, oxygen and related chronic home therapy services
The latest updates
- AdaptHealth Corp., a leading provider of home-based health care equipment, home-based medical supplies and associated services in the US, today announced financial results for the three or six-months NASDAQ: AHCO.
- During the second quarter of 2020, AdaptHealth reported high revenue and productivity helped by its ability to deliver essential medical services and resources to referral partners during the COVID-19 pandeme.
- On 1 July 2020 Solara Medical Supplies and ActivStyle acquisitions were sold. These acquisitions improve the recurring sector of resupplying and extend the role of AdaptHealth in the increasingly increasing ongoing tracking market for glucose.
- The Company finalized $1.2 billion of financing in July 2020. These included net revenue of $134 million from primary equities issues, $225 million from PIPE, $343 million net revenue from unsecured senior note issuance, and a refinancing-facilities for senior banks of $450 million, which resulted in considerable liquidity to promote the strategic priorities of the Company.
- The Group financed the July acquisitions and thus had ample equity, a balanced financial arrangement between secured loan loans and unsecured bonds, and a net interest ratio of less than 3X EBITDA.
Findings of the second quarter
- Patient Care Solutions (PCS), which was bought in January 2020 and created a net sale of $33.0 million, rose 87% from the first quarter of 2019 and 21% more than the first quarter of 2020.
- The Company has recorded $28.4 million of net income in support of its emergency needs for ventilator and respiratory equipment of COVID-19 patients to referral partners and healthcare facilities.
- The total income of NASDAQ: AHCO in the second quarter of 2019 was 4.0 million dollars, or 0.08 percent per diluted share, relative to a net loss of 2.1 million dollars or 0.10 cents on each diluted share.
- CAPEX’s adjusted EBITDA was $30.6 million less in the second quarter 2019 compared to $18.1 million. The reported EBITDA minus Patient Equipment Capex and PCS which incurred a quarterly loss of $3.6 million, up by 89 percent relative to the second trimester of 2019.
- The reported EBITDA in the second quarter of 2019 was 42,6 million dollars, compared with 29,5 million dollars. The EBITDA adjusted was $46.2 million, which is 57 percent higher than in the second quarter of 2019 than the PCS that reported a quarterly loss of $3.6 million. You can do stock trading from margin account.
Disclaimer: The analysis information is for reference only and does not constitute an investment recommendation.